243 related articles for article (PubMed ID: 24420545)
21. Visinin-like 1 is upregulated in aldosterone-producing adenomas with KCNJ5 mutations and protects from calcium-induced apoptosis.
Williams TA; Monticone S; Crudo V; Warth R; Veglio F; Mulatero P
Hypertension; 2012 Apr; 59(4):833-9. PubMed ID: 22331379
[TBL] [Abstract][Full Text] [Related]
22. Comparative Genomics and Transcriptome Profiling in Primary Aldosteronism.
Aristizabal Prada ET; Castellano I; Sušnik E; Yang Y; Meyer LS; Tetti M; Beuschlein F; Reincke M; Williams TA
Int J Mol Sci; 2018 Apr; 19(4):. PubMed ID: 29642543
[TBL] [Abstract][Full Text] [Related]
23. An update on novel mechanisms of primary aldosteronism.
Zennaro MC; Boulkroun S; Fernandes-Rosa F
J Endocrinol; 2015 Feb; 224(2):R63-77. PubMed ID: 25424518
[TBL] [Abstract][Full Text] [Related]
24. Comprehensive re-sequencing of adrenal aldosterone producing lesions reveal three somatic mutations near the KCNJ5 potassium channel selectivity filter.
Åkerström T; Crona J; Delgado Verdugo A; Starker LF; Cupisti K; Willenberg HS; Knoefel WT; Saeger W; Feller A; Ip J; Soon P; Anlauf M; Alesina PF; Schmid KW; Decaussin M; Levillain P; Wängberg B; Peix JL; Robinson B; Zedenius J; Bäckdahl M; Caramuta S; Iwen KA; Botling J; Stålberg P; Kraimps JL; Dralle H; Hellman P; Sidhu S; Westin G; Lehnert H; Walz MK; Åkerström G; Carling T; Choi M; Lifton RP; Björklund P
PLoS One; 2012; 7(7):e41926. PubMed ID: 22848660
[TBL] [Abstract][Full Text] [Related]
25. Genetics of Primary Aldosteronism.
Scholl UI
Hypertension; 2022 May; 79(5):887-897. PubMed ID: 35139664
[TBL] [Abstract][Full Text] [Related]
26. K+ channel mutations in adrenal aldosterone-producing adenomas and hereditary hypertension.
Choi M; Scholl UI; Yue P; Björklund P; Zhao B; Nelson-Williams C; Ji W; Cho Y; Patel A; Men CJ; Lolis E; Wisgerhof MV; Geller DS; Mane S; Hellman P; Westin G; Åkerström G; Wang W; Carling T; Lifton RP
Science; 2011 Feb; 331(6018):768-72. PubMed ID: 21311022
[TBL] [Abstract][Full Text] [Related]
27. Genetic, Cellular, and Molecular Heterogeneity in Adrenals With Aldosterone-Producing Adenoma.
De Sousa K; Boulkroun S; Baron S; Nanba K; Wack M; Rainey WE; Rocha A; Giscos-Douriez I; Meatchi T; Amar L; Travers S; Fernandes-Rosa FL; Zennaro MC
Hypertension; 2020 Apr; 75(4):1034-1044. PubMed ID: 32114847
[TBL] [Abstract][Full Text] [Related]
28. a Novel Y152C KCNJ5 mutation responsible for familial hyperaldosteronism type III.
Monticone S; Hattangady NG; Penton D; Isales CM; Edwards MA; Williams TA; Sterner C; Warth R; Mulatero P; Rainey WE
J Clin Endocrinol Metab; 2013 Nov; 98(11):E1861-5. PubMed ID: 24037882
[TBL] [Abstract][Full Text] [Related]
29. Novel genes in primary aldosteronism.
Fischer E; Beuschlein F
Curr Opin Endocrinol Diabetes Obes; 2014 Jun; 21(3):154-8. PubMed ID: 24739312
[TBL] [Abstract][Full Text] [Related]
30. Characterization of a novel somatic KCNJ5 mutation delI157 in an aldosterone-producing adenoma.
Murthy M; Azizan EA; Brown MJ; O'Shaughnessy KM
J Hypertens; 2012 Sep; 30(9):1827-33. PubMed ID: 22743686
[TBL] [Abstract][Full Text] [Related]
31. Genetic variations in the KCNJ5 gene in primary aldosteronism patients from Xinjiang, China.
Li NF; Li HJ; Zhang DL; Zhang JH; Yao XG; Wang HM; Abulikemu S; Zhou KM; Zhang XY
PLoS One; 2013; 8(1):e54051. PubMed ID: 23382865
[TBL] [Abstract][Full Text] [Related]
32. NCI-H295R cell line as in vitro model of hyperaldosteronism lacks functional KCNJ5 (GIRK4; Kir3.4) channels.
Kienitz MC; Mergia E; Pott L
Mol Cell Endocrinol; 2015 Sep; 412():272-80. PubMed ID: 25998841
[TBL] [Abstract][Full Text] [Related]
33. KCNJ5 gene somatic mutations affect cardiac remodelling but do not preclude cure of high blood pressure and regression of left ventricular hypertrophy in primary aldosteronism.
Rossi GP; Cesari M; Letizia C; Seccia TM; Cicala MV; Zinnamosca L; Kuppusamy M; Mareso S; Sciomer S; Iacobone M; Mantero F; Pessina AC
J Hypertens; 2014 Jul; 32(7):1514-21; discussion 1522. PubMed ID: 24759126
[TBL] [Abstract][Full Text] [Related]
34. Genetic causes of primary aldosteronism.
Seidel E; Schewe J; Scholl UI
Exp Mol Med; 2019 Nov; 51(11):1-12. PubMed ID: 31695023
[TBL] [Abstract][Full Text] [Related]
35. Update on the Genetics of Primary Aldosteronism and Aldosterone-Producing Adenomas.
Pitsava G; Faucz FR; Stratakis CA; Hannah-Shmouni F
Curr Cardiol Rep; 2022 Sep; 24(9):1189-1195. PubMed ID: 35841527
[TBL] [Abstract][Full Text] [Related]
36. KCNJ5 mutations in the National Institutes of Health cohort of patients with primary hyperaldosteronism: an infrequent genetic cause of Conn's syndrome.
Xekouki P; Hatch MM; Lin L; Rodrigo de A; Azevedo M; de la Luz Sierra M; Levy I; Saloustros E; Moraitis A; Horvath A; Kebebew E; Hoffman DA; Stratakis CA
Endocr Relat Cancer; 2012 Jun; 19(3):255-60. PubMed ID: 22323562
[TBL] [Abstract][Full Text] [Related]
37. Primary aldosteronism: a channelopathy?
Gomez-Sanchez CE
Hypertension; 2014 Apr; 63(4):668-9. PubMed ID: 24420546
[No Abstract] [Full Text] [Related]
38. Somatic mutations in the KCNJ5 gene raise the lateralization index: implications for the diagnosis of primary aldosteronism by adrenal vein sampling.
Seccia TM; Mantero F; Letizia C; Kuppusamy M; Caroccia B; Barisa M; Cicala MV; Miotto D; Rossi GP
J Clin Endocrinol Metab; 2012 Dec; 97(12):E2307-13. PubMed ID: 23012392
[TBL] [Abstract][Full Text] [Related]
39. Characteristics of Japanese aldosterone-producing adenomas with KCNJ5 mutations.
Okamura T; Nakajima Y; Katano-Toki A; Horiguchi K; Matsumoto S; Yoshino S; Yamada E; Tomaru T; Ishii S; Saito T; Ozawa A; Shibusawa N; Satoh T; Okada S; Nagaoka R; Takada D; Horiguchi J; Oyama T; Yamada M
Endocr J; 2017 Jan; 64(1):39-47. PubMed ID: 27681703
[TBL] [Abstract][Full Text] [Related]
40. Primary aldosteronism caused by a pI157S somatic
Gomez-Sanchez CE; van Rooyen D; Rainey WE; Nanba K; Blinder AR; Baliga R
Front Endocrinol (Lausanne); 2022; 13():921449. PubMed ID: 36051386
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
